Steering cell migration: lamellipodium dynamics and the regulation of directional persistence
M Krause, A Gautreau - Nature reviews Molecular cell biology, 2014 - nature.com
Membrane protrusions at the leading edge of cells, known as lamellipodia, drive cell
migration in many normal and pathological situations. Lamellipodial protrusion is powered …
migration in many normal and pathological situations. Lamellipodial protrusion is powered …
The Arp2/3 regulatory system and its deregulation in cancer
N Molinie, A Gautreau - Physiological reviews, 2018 - journals.physiology.org
The Arp2/3 complex is an evolutionary conserved molecular machine that generates
branched actin networks. When activated, the Arp2/3 complex contributes the actin …
branched actin networks. When activated, the Arp2/3 complex contributes the actin …
DNA methylation map of human atherosclerosis
Background—Epigenetic alterations may contribute to the development of atherosclerosis.
In particular, DNA methylation, a reversible and highly regulated DNA modification, could …
In particular, DNA methylation, a reversible and highly regulated DNA modification, could …
The atypical mechanosensitive microRNA-712 derived from pre-ribosomal RNA induces endothelial inflammation and atherosclerosis
MicroRNAs (miRNAs) regulate cardiovascular biology and disease, but the role of flow-
sensitive microRNAs in atherosclerosis is still unclear. Here we identify miRNA-712 (miR …
sensitive microRNAs in atherosclerosis is still unclear. Here we identify miRNA-712 (miR …
Development and clinical validation of novel 8-gene prognostic signature associated with the proportion of regulatory T cells by weighted gene co-expression network …
J Liu, R Geng, S Yang, F Shao, Z Zhong… - Frontiers in …, 2021 - frontiersin.org
Background Uterine corpus endometrial carcinoma (UCEC) is a gynecological malignant
tumor with low survival rate and poor prognosis. The traditional clinicopathological staging is …
tumor with low survival rate and poor prognosis. The traditional clinicopathological staging is …
NOX4-derived reactive oxygen species limit fibrosis and inhibit proliferation of vascular smooth muscle cells in diabetic atherosclerosis
E Di Marco, SP Gray, K Kennedy… - Free Radical Biology …, 2016 - Elsevier
Smooth muscle cell (SMC) proliferation and fibrosis contribute to the development of
advanced atherosclerotic lesions. Oxidative stress caused by increased production or …
advanced atherosclerotic lesions. Oxidative stress caused by increased production or …
Inhibition of vascular neointima hyperplasia by FGF21 associated with FGFR1/Syk/NLRP3 inflammasome pathway in diabetic mice
W Wei, XX Li, M Xu - Atherosclerosis, 2019 - Elsevier
Background and aims Neointima hyperplasia is the pathological basis of atherosclerosis
and restenosis, which have been associated with diabetes mellitus (DM). Fibroblast growth …
and restenosis, which have been associated with diabetes mellitus (DM). Fibroblast growth …
Cancer stem cell marker DCLK1 reprograms small extracellular vesicles toward migratory phenotype in gastric cancer cells
Abstract Doublecortin‐like kinase 1 (DCLK1) is a putative cancer stem cell marker, a
promising diagnostic and prognostic maker for malignant tumors and a proposed driver …
promising diagnostic and prognostic maker for malignant tumors and a proposed driver …
[HTML][HTML] Increased aerobic glycolysis is important for the motility of activated VSMC and inhibited by indirubin-3′-monoxime
EH Heiss, D Schachner, M Donati, CS Grojer… - Vascular …, 2016 - Elsevier
Increased aerobic glycolysis is a recognized feature of multiple cellular phenotypes and
offers a potential point for drug interference, as pursued by anti-tumor agents targeting the …
offers a potential point for drug interference, as pursued by anti-tumor agents targeting the …
[HTML][HTML] Lenalidomide interferes with tumor-promoting properties of nurse-like cells in chronic lymphocytic leukemia
S Fiorcari, S Martinelli, J Bulgarelli, V Audrito… - …, 2015 - ncbi.nlm.nih.gov
Lenalidomide is an immunomodulatory agent clinically active in chronic lymphocytic
leukemia patients. The specific mechanism of action is still undefined, but includes …
leukemia patients. The specific mechanism of action is still undefined, but includes …